ORSENSE'S NON-INVASIVE CONTINUOUS GLUCOSE MONITORING SYSTEM ACHIEVES ACCURATE PERFORMANCE IN HOME USE SETTING

Results Presented at the Scientific Session of the 66th American Diabetes Association (ADA) Show Median Relative Absolute Difference of 12.9% in a Wide Range of Glucose Levels. Results of a study by a group of clinicians at the Chaim Sheba Medical Center, presented at the 66th Scientific Session of the American Diabetes Association (ADA) taking place June 9-13, 2006 in Washington, D.C., indicate that the NBM-100G, a non-invasive continuous glucose monitoring sensor developed by OrSense Ltd., accurately measures levels of glucose in a home like setting.
Genetic Engineering News